SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
3449BERLIN and SEATTLE, April 3 /PRNewswire/ -- Epigenomics AG, a biotech company denigel bates4/3/2003
3448You should feel good about that. Others are working with nanospheres-:)John Metcalf3/31/2003
3447Damn! I just got my old BB gun out the other day.scaram(o)uche3/31/2003
3446OT: Guffaw! So the President is fond of playing marbles? <g>The Dodgy Ticker3/31/2003
3445After a two year long study, the National Science Foundation announced the folloscaram(o)uche3/29/2003
3444Clowns, clowns, clowns (IMO). Pass it on. <i>Biotechnology, Genomics Darscaram(o)uche3/24/2003
3443MitoKor pulls stock offer due to market conditions Monday March 24, 4:16 pm ET scaram(o)uche3/24/2003
3442These guys are, IMO, clowns/a joke. Moreover, I've seen claims that theyscaram(o)uche3/22/2003
3441ReCap nominations are out for ALLICENSE 2003 Breakthrough Alliance..... Aventisscaram(o)uche3/19/2003
3440Another chunk... LONDON -(Dow Jones)- German biotechnology company Cellzome Gmbnigel bates3/18/2003
3439Nice chunk of change. A few chunks being thrown around of late, particularly byscaram(o)uche3/17/2003
3438WORCESTER, Mass.--(BUSINESS WIRE)--March 17, 2003-- Hypnion, Inc. today announcenigel bates3/17/2003
3437Abercrombie is on CNBC now, talking about pundits who said that Fuzeon couldnscaram(o)uche3/14/2003
3436DURHAM, N.C., March 14 /PRNewswire-FirstCall/ -- Inspire Pharmaceuticals, Inc. (nigel bates3/14/2003
3435GLFD at 3.70 has 3.30 per share in cash and was just upgraded by Raymond James..RRICH43/14/2003
3434U.S. FDA Approves FUZEON(TM); First Drug to Block Entry of HIV into Immune Cellsscaram(o)uche3/13/2003
3433Biomedical Firms See Flow of Funds Slow to a Trickle Speakers at a confesim13/13/2003
3432Strominger used to send me mice, mice that I needed to do a given set of experimscaram(o)uche3/12/2003
3431CAMBRIDGE, Mass., March 12 /PRNewswire/ -- Peptimmune, Inc. has secured $41.2 minigel bates3/12/2003
3430Scleroderma Foundation Appoints New Poster Child and New Teen Ambassador To Educscaram(o)uche3/6/2003
3429Screw Celltech.scaram(o)uche3/6/2003
3428>> too bad BVF did not own VGNX << Chambon Formella Vogelbaum IMO,scaram(o)uche3/3/2003
3427too bad BVF did not own VGNX...I still like lampert.mopgcw3/3/2003
3426BVF on Corvas...... Message 18652170scaram(o)uche3/3/2003
3425Dow Jones Business News Celgene On Track For First Annual Profit, CEO Says >Cscaram(o)uche2/27/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News